Welcome to our dedicated page for AINOS news (Ticker: AIMDW), a resource for investors and traders seeking the latest updates and insights on AINOS stock.
Ainos, Inc. (AIMD, AIMDW) generates news around its efforts to digitize smell for artificial intelligence and to build a SmellTech platform that combines hardware, software, and data. Company updates frequently highlight progress with its AI Nose electronic nose system, the Smell ID data format, and the Smell Language Model (SLM), as well as developments in its biotech program centered on the oral interferon candidate VELDONA.
News coverage for Ainos often focuses on industrial and technology partnerships. The company has announced collaborations with semiconductor solution providers, industrial computing and edge AI companies, and automation and robotics firms to integrate AI Nose into manufacturing and industrial environments. These stories describe how AI Nose is being deployed in semiconductor fabrication, smart factories, and robotic systems to provide real-time environmental sensing, predictive analytics, and alerts.
Investors can also find corporate and capital markets updates in Ainos-related news, including information on its Global Industry Classification Standard reclassification into the technology sector, At The Market Offering Agreement activity, and reverse stock split of its common stock. Earnings releases and business updates provide context on commercialization milestones, pilot programs in senior care and robotics, and the expansion of the company’s SmellTech-as-a-Service model.
For those following AIMDW, the warrant listing associated with Ainos common stock, the news stream offers insight into the company’s strategic direction, platform evolution, and partnerships. Regularly reviewing these articles can help readers understand how Ainos is positioning AI Nose and ScentAI within semiconductors, edge AI, healthcare, and robotics, and how these initiatives relate to its broader dual-platform AI and biotech strategy.
Ainos (NASDAQ:AIMD) announced a strategic partnership with Mirle to integrate its AI Nose SmellTech into Mirle's mobile and quadruped robotic platforms, extending deployments from commercial buildings into industrial environments such as semiconductor fabs and advanced manufacturing.
The collaboration aims to add chemical sensing to vision and audio, improve early detection of gas leaks and VOCs, and accelerate real-world data collection to scale the Smell ID library and platform capabilities.
Ainos (NASDAQ:AIMD) is advancing its AI Nose SmellTech platform, positioning scent as a native AI data layer through standardized Smell IDs and a proprietary Smell Language Model. The company reported multi-year semiconductor back-end orders of approximately $2.1M for ~1,400 AI Nose units and highlighted robotics partnerships to scale continuous scent data generation in 2026.
The firm's dual-engine architecture separates physical sensing from intelligence-as-a-service (via subsidiary ScentAI) to pursue recurring subscription economics, broader industrial deployments across front-end and back-end semiconductor operations, and accelerated data flywheel growth via robotics partnerships.
Ainos (NASDAQ:AIMD) announced a technology partnership with Mirle Automation on February 2, 2026, to integrate Ainos' AI Nose scent‑digitizing platform into mobile and quadruped robotic platforms.
The collaboration targets inspection, monitoring, and autonomous tasks — detecting VOCs, gas leaks, and chemical anomalies — to boost robotic situational awareness and safety across fabs, manufacturing, healthcare, outdoor inspection, and security applications.
Ainos (NASDAQ:AIMD / AIMDW) will participate in a fireside chat with Water Tower Research on Monday, January 26, 2026 at 11:00 a.m. ET.
The company will discuss its dual-engine SmellTech platform, partnership with Trusval Technology, progress scaling AI Nose technology toward commercial deployment, and strategic priorities for 2026. The event is listen-only and a replay will be posted under "Events" on Ainos' investor relations site.
Ainos (NASDAQ:AIMD) is advancing AI Nose from R&D toward scaled commercial deployment in 2026, supported by a dual-engine architecture separating hardware sensing and a software ScentAI layer. A three-year distribution and deployment agreement with Trusval Technology includes an initial minimum commitment of 600 AI Nose units, targeting front-end semiconductor wafer fabrication and broader manufacturing use cases. The structure aims to enable recurring, SaaS-style revenue through APIs, licensing, and subscriptions while expanded deployments feed a growing Smell ID library and machine-learning performance. Ainos relocated its U.S. headquarters to Houston, Texas in early 2026 to align with industrial and semiconductor ecosystems.
Ainos (NASDAQ:AIMD) announced a distribution and deployment agreement with Taiwan-based Trusval Technology on January 7, 2026 to expand AI Nose into semiconductor front-end manufacturing.
Under the contract, Trusval will be Ainos' authorized sales agent and deployment partner for front-end wafer fab applications, with an initial minimum purchase commitment of 600 AI Nose units to support real-world deployments and scent data accumulation in high-precision manufacturing environments.
The deal extends Ainos' SmellTech footprint upstream from back-end processes and aligns with the company's 2026 execution focus on disciplined, contract‑driven platform expansion.
Ainos (NASDAQ:AIMD) outlined a long-term platform strategy to digitize smell as a native AI data language and described a dual-engine SmellTech architecture split between hardware sensing and AI intelligence.
Ainos will own design, manufacturing, deployment, and data generation for its AI Nose sensors while wholly owned ScentAI will develop the Smell Language Model (SLM) to classify, contextualize, and scale scent data via APIs, SaaS, and model licensing. 2026 priorities target scaled deployments in advanced semiconductor manufacturing and robotics to accelerate data accumulation and SLM training.
Ainos (NASDAQ:AIMD / AIMDW) will relocate its U.S. headquarters to Houston, Texas in early 2026 and has formed a wholly owned software subsidiary, ScentAI Inc.
ScentAI will develop a smell language model (SLM) that converts scent signals into Smell ID tokens and will be co-located with Ainos' HQ to integrate AI Nose hardware data with model development. Management described the move as improving operating efficiency and enabling U.S. commercialization after recent deployments in Asia.
Ainos (NASDAQ:AIMD) reported third-quarter 2025 developments as it accelerates commercial scale-up of its AI Nose scent‑digitization platform ahead of 2026. Key operational moves include expanding industrial partnerships to six, a distribution agreement with Topco across the U.S., Taiwan, Japan and Southeast Asia, a strategic partnership with NEXCOM (Oct 14, 2025), and reclassification under GICS to Technology Hardware, Storage & Peripherals effective Oct 1, 2025. The company launched its first commercial portable AI Nose (Aug 14, 2025) and added seven patents on Sep 30, 2025, bringing the total to 123 active patents. Management cited cost discipline with S,G&A down 22% YoY and total operating expenses down 8%.
Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM to integrate its AI Nose scent‑based edge AI solution into NEXCOM's industrial edge computing and automation platforms. The collaboration is Ainos' sixth industrial partnership in 2025 and aims to enable real‑time environmental sensing, predictive maintenance, and improved sustainability by processing olfactory data at the edge instead of the cloud. The deal leverages NEXCOM's network of 117 partners across 50 countries and aligns with an edge AI market projected at $57–$66 billion by 2030. Ainos targets a commercial launch in 2026 for AI Nose and cites enhanced industrial channels via NEXCOM's global footprint.
FAQ
What is the current stock price of AINOS (AIMDW)?
